452 related articles for article (PubMed ID: 32402335)
1. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
[TBL] [Abstract][Full Text] [Related]
2. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
5. Effect of vaccination route (intradermal vs. intramuscular) against porcine reproductive and respiratory syndrome using a modified live vaccine on systemic and mucosal immune response and virus transmission in pigs.
Renson P; Mahé S; Andraud M; Le Dimna M; Paboeuf F; Rose N; Bourry O
BMC Vet Res; 2024 Jan; 20(1):5. PubMed ID: 38172908
[TBL] [Abstract][Full Text] [Related]
6. Using a concurrent challenge with porcine circovirus 2 and porcine reproductive and respiratory syndrome virus to compare swine vaccination programs.
Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
Sci Rep; 2022 Sep; 12(1):15524. PubMed ID: 36109529
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R
Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207
[TBL] [Abstract][Full Text] [Related]
10. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
[TBL] [Abstract][Full Text] [Related]
11. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
[TBL] [Abstract][Full Text] [Related]
12. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.
Ouyang K; Hiremath J; Binjawadagi B; Shyu DL; Dhakal S; Arcos J; Schleappi R; Holman L; Roof M; Torrelles JB; Renukaradhya GJ
Vet Res; 2016 Mar; 47():45. PubMed ID: 26988085
[TBL] [Abstract][Full Text] [Related]
14. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
[TBL] [Abstract][Full Text] [Related]
16. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
Charerntantanakul W; Pongjaroenkit S
Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a type 2 PRRSV modified live vaccine (PrimePac™ PRRS) against a Thai HP-PRRSV challenge.
Sirisereewan C; Woonwong Y; Arunorat J; Kedkovid R; Nedumpun T; Kesdangsakonwut S; Suradhat S; Thanawongnuwech R; Teankum K
Trop Anim Health Prod; 2018 Oct; 50(7):1509-1518. PubMed ID: 29696456
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
Park C; Seo HW; Han K; Kang I; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
[TBL] [Abstract][Full Text] [Related]
20. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
